These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 22442051)

  • 1. Extracellular vesicles--vehicles that spread cancer genes.
    Rak J; Guha A
    Bioessays; 2012 Jun; 34(6):489-97. PubMed ID: 22442051
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extracellular vesicle communication pathways as regulatory targets of oncogenic transformation.
    Choi D; Lee TH; Spinelli C; Chennakrishnaiah S; D'Asti E; Rak J
    Semin Cell Dev Biol; 2017 Jul; 67():11-22. PubMed ID: 28077296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The roles of extracellular vesicles in cancer biology: toward the development of novel cancer biomarkers.
    Katsuda T; Kosaka N; Ochiya T
    Proteomics; 2014 Mar; 14(4-5):412-25. PubMed ID: 24339442
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of the tissue factor pathway in the biology of tumor initiating cells.
    Garnier D; Milsom C; Magnus N; Meehan B; Weitz J; Yu J; Rak J
    Thromb Res; 2010 Apr; 125 Suppl 2():S44-50. PubMed ID: 20434004
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intercellular transfer of the oncogenic receptor EGFRvIII by microvesicles derived from tumour cells.
    Al-Nedawi K; Meehan B; Micallef J; Lhotak V; May L; Guha A; Rak J
    Nat Cell Biol; 2008 May; 10(5):619-24. PubMed ID: 18425114
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of the regulatory design on the response of epidermal growth factor receptor-mediated signal transduction towards oncogenic mutations.
    Wolf J; Dronov S; Tobin F; Goryanin I
    FEBS J; 2007 Nov; 274(21):5505-17. PubMed ID: 17916191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extracellular vesicles in the biology of brain tumour stem cells--Implications for inter-cellular communication, therapy and biomarker development.
    Nakano I; Garnier D; Minata M; Rak J
    Semin Cell Dev Biol; 2015 Apr; 40():17-26. PubMed ID: 25721810
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oncogenic extracellular vesicles in brain tumor progression.
    D'Asti E; Garnier D; Lee TH; Montermini L; Meehan B; Rak J
    Front Physiol; 2012; 3():294. PubMed ID: 22934045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of tumor-and host-related tissue factor pools in oncogene-driven tumor progression.
    Milsom C; Yu J; May L; Meehan B; Magnus N; Al-Nedawi K; Luyendyk J; Weitz J; Klement P; Broze G; Mackman N; Rak J
    Thromb Res; 2007; 120 Suppl 2():S82-91. PubMed ID: 18023719
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of ErbB receptor signalling in cancer cells by microRNA.
    Barker A; Giles KM; Epis MR; Zhang PM; Kalinowski F; Leedman PJ
    Curr Opin Pharmacol; 2010 Dec; 10(6):655-61. PubMed ID: 20864407
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular mechanisms of signal transduction: epidermal growth factor receptor family, vascular endothelial growth factor family, Kit, platelet-derived growth factor receptor, Ras.
    Erman M
    J BUON; 2007 Sep; 12 Suppl 1():S83-94. PubMed ID: 17935283
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extracellular vesicles - biomarkers and effectors of the cellular interactome in cancer.
    Rak J
    Front Pharmacol; 2013; 4():21. PubMed ID: 23508692
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tissue factor and cancer stem cells: is there a linkage?
    Milsom C; Magnus N; Meehan B; Al-Nedawi K; Garnier D; Rak J
    Arterioscler Thromb Vasc Biol; 2009 Dec; 29(12):2005-14. PubMed ID: 19628788
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumorigenic conversion of primary human esophageal epithelial cells using oncogene combinations in the absence of exogenous Ras.
    Kim SH; Nakagawa H; Navaraj A; Naomoto Y; Klein-Szanto AJ; Rustgi AK; El-Deiry WS
    Cancer Res; 2006 Nov; 66(21):10415-24. PubMed ID: 17079462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Oncogenes and tumor suppressor genes in the signal transduction pathways of growth factors].
    Buday L
    Orv Hetil; 1994 Nov; 135(47):2579-84. PubMed ID: 7824256
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oncogenic synergism between ErbB1, nucleolin, and mutant Ras.
    Farin K; Schokoroy S; Haklai R; Cohen-Or I; Elad-Sfadia G; Reyes-Reyes ME; Bates PJ; Cox AD; Kloog Y; Pinkas-Kramarski R
    Cancer Res; 2011 Mar; 71(6):2140-51. PubMed ID: 21257709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. EGFR promotes lung tumorigenesis by activating miR-7 through a Ras/ERK/Myc pathway that targets the Ets2 transcriptional repressor ERF.
    Chou YT; Lin HH; Lien YC; Wang YH; Hong CF; Kao YR; Lin SC; Chang YC; Lin SY; Chen SJ; Chen HC; Yeh SD; Wu CW
    Cancer Res; 2010 Nov; 70(21):8822-31. PubMed ID: 20978205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A critical role for ras-mediated, epidermal growth factor receptor-dependent angiogenesis in mouse skin carcinogenesis.
    Casanova ML; Larcher F; Casanova B; Murillas R; Fernández-Aceñero MJ; Villanueva C; Martínez-Palacio J; Ullrich A; Conti CJ; Jorcano JL
    Cancer Res; 2002 Jun; 62(12):3402-7. PubMed ID: 12067982
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tissue factor in cancer and angiogenesis: the molecular link between genetic tumor progression, tumor neovascularization, and cancer coagulopathy.
    Rak J; Milsom C; May L; Klement P; Yu J
    Semin Thromb Hemost; 2006 Feb; 32(1):54-70. PubMed ID: 16479463
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oncogenes and tumor angiogenesis: the question of vascular "supply" and vascular "demand".
    Rak J; Yu JL
    Semin Cancer Biol; 2004 Apr; 14(2):93-104. PubMed ID: 15018893
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.